Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
1.110
-0.020 (-1.77%)
Feb 23, 2026, 4:00 PM EST - Market closed

Standard BioTools Revenue

Standard BioTools had revenue of $19.55M in the quarter ending September 30, 2025, a decrease of -11.47%. This brings the company's revenue in the last twelve months to $128.83M, up 8.89% year-over-year. In the year 2024, Standard BioTools had annual revenue of $174.43M with 64.03% growth.

Revenue (ttm)
$128.83M
Revenue Growth
+8.89%
P/S Ratio
2.51
Revenue / Employee
$207,502
Employees
818
Market Cap
426.87M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024174.43M68.09M64.03%
Dec 31, 2023106.34M8.39M8.57%
Dec 31, 202297.95M-32.63M-24.99%
Dec 31, 2021130.58M-7.56M-5.47%
Dec 31, 2020138.14M20.90M17.83%
Dec 31, 2019117.24M4.28M3.79%
Dec 31, 2018112.96M11.03M10.82%
Dec 31, 2017101.94M-2.51M-2.40%
Dec 31, 2016104.45M-10.27M-8.95%
Dec 31, 2015114.71M-1.74M-1.50%
Dec 31, 2014116.46M45.27M63.60%
Dec 31, 201371.18M18.85M36.02%
Dec 31, 201252.33M9.47M22.09%
Dec 31, 201142.87M9.31M27.73%
Dec 31, 201033.56M8.15M32.06%
Dec 31, 200925.41M10.07M65.58%
Dec 27, 200815.35M8.07M110.96%
Dec 29, 20077.28M877.00K13.71%
Dec 31, 20066.40M-1.28M-16.63%
Dec 31, 20057.67M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Orthofix Medical818.06M
OrthoPediatrics227.41M
Cerus199.19M
Cytek Biosciences196.83M
Pacific Biosciences of California160.01M
RxSight142.09M
NeuroPace94.86M
Delcath Systems79.60M
Revenue Rankings